An observational study assessing efficacy of alemtuzumab in patients with aggressive multiple sclerosis: a real world study
Latest Information Update: 29 Oct 2018
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 12 Oct 2018 Results assessing the NEDA-3 and disability regression in patients with multiple scelorsis treated with alemtuzumab, presented at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.
- 18 Nov 2016 New trial record